Ever since Donna and John met at work three decades ago, they've had the kind of smooth, comfortable relationship that comes when attraction is accompanied by compatible interests as well as strengths and weaknesses that balance each other. They pictured their senior years as an extension of what Donna Dean calls “this nice, easy life. We didn't see the calamity that was coming.”
Brookdale Senior Living, the nation's largest dementia care provider, has created new resources for care partners as part of National Alzheimer's Awareness Month in November. The candid discussion of many of the disease's most difficult challenges includes an up-close look at Donna's and John’s lives since he developed dementia.
The couple shares on video how following John's diagnosis, they adapted and sustained daily routines, emotional connection and affection. Donna speaks of her uncertainties about how to manage her reactions to behavioral expressions, the adjustment to John's move to a dementia care community and how keeping a journal helped her logistically and emotionally.
To view the multimedia release go to:
http://www.multivu.com/players/English/7722131-brookdale-alzheimers-awareness/
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that The New England Journal of Medicine has published results from a Phase 3 study of Epidiolex® (cannabidiol) in children with Dravet syndrome.1 Epidiolex, GW’s lead product candidate and the potential first in a new category of anti-epileptic drugs, is a liquid formulation of purified, plant-derived cannabidiol (CBD), a non-psychoactive cannabinoid, which is being studied for the treatment of a number of rare, severe pediatric-onset epilepsy disorders. In the study, Epidiolex significantly reduced monthly convulsive seizure frequency compared to placebo in highly treatment-resistant children when added to existing treatment. Treatment with Epidiolex was generally well tolerated, with a safety profile consistent with prior open label experience.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8109951-gw-pharmaceuticals-study-epidiolex/
In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community.
St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature.
“Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
Playing the harmonica, dancing, bowling: For Brookdale Senior Living resident Dorothy Plummer, these longtime passions bring purpose as well as pleasure to daily life. What may be surprising is that Plummer is not only 103 – she is living with dementia. Plummer embodies Brookdale’s mission of person-centered care, which focuses on sustaining individual interests and daily routines to give meaning to each person’s life. As part of National Alzheimer’s Disease Awareness Month, Brookdale is offering a free downloadable journal to help others with dementia look for ways to live life to the fullest.
“When people hear someone has Alzheimer’s, the label of the disease can unfortunately replace who the person is,” said Juliet Holt Klinger, senior director of dementia care for Brookdale. “Their life becomes shaped by the diagnosis. The things they love to do may be taken away when they don’t need to be. This can cause disengagement, potentially leading to depression, isolation, loss of appetite, weight loss, and even falls.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7722151-brookdale-senior-living-alzheimers-awareness/
Researchers at global public health organization NSF International, Harvard Medical School, the United States Department of Defense and the National Institute for Public Health and the Environment in the Netherlands (RIVM) recently identified four unapproved, DMAA-like stimulants in six over-the-counter weight-loss and pre-workout products currently available online. The research was published in the peer-reviewed journal Clinical Toxicology.
The potentially harmful compounds – including banned stimulants 1,3-DMAA and 1,3-DMBA as well as octodrine and a newly identified DMAA analog – were not listed as ingredients in the products and may have been disguised as “2-aminoisoheptane” or extract of Aconitum kusnezoffii. These stimulants may cause adverse cardiac events, hemorrhagic strokes or sudden death, especially if taken prior to strenuous exercise or combined with caffeine. Extreme heat and dehydration may also increase the health risks.
To view the multimedia release go to:
https://www.multivu.com/players/English/8216951-nsf-international-banned-stimulants-2-aminoisoheptane/
Moon Hoax -Astronaut Does a Ballet Dance at Ballet Crater in Fake Moon Bay.
NASA video as you hear & see it, is located for download at NASA site:
http://history.nasa.gov/alsj/a17/video17.html
Apollo 17 Video Library
Geology Station 3 at Ballet Crater
Journal Text: 144:50:23 RealVideo Clip: (3 minutes 50 seconds)
Journal Text: 144:54:04 RealVideo Clip: (4 minutes 21 seconds)
Moon Hoax -Astronauts & Houston Talk About High Roof Bay Fake Moon Set.
NASA video as you hear it, is located for download at NASA site:
http://history.nasa.gov/alsj/a16/video16.html
Apollo 16 Video Library
House Rock
Journal Text: 167:47:53
Astronauts Pretend to Take Photos in the Nevada Fake Moon Bay.
NASA video as you hear & see it, is located for download at NASA site:
http://history.nasa.gov/alsj/a17/video17.html
Apollo 17 Video Library
Journal Text: 144:40:02
Journal Text: 144:47:00
Journal Text: 145:00:57
Journal Text: 145:51:22
ALL NASA FOOTAGE USED IN THIS FILM IS PUBLIC DOMAIN. THE USE OF ANY COPYRIGHTED MATERIAL IS USED UNDER THE GUIDELINES OF "FAIR USE" IN TITLE 17 § 107 OF THE UNITED STATES CODE. SUCH MATERIAL REMAINS THE COPYRIGHT OF THE ORIGINAL HOLDER AND IS USED HERE FOR THE PURPOSES OF EDUCATION, COMPARISON, AND CRITICISM ONLY. NO INFRINGEMENT OF COPYRIGHT IS INTENDED.
Ceiling Stagehands Have Tech Problems With The Fake Cable Pull-up of The Lunar Module in The Nevada Fake Moon Bay.
NASA video as you hear & see it, is located for download at NASA site:
http://history.nasa.gov/alsj/a17/video17.html
Apollo 17 Video Library
Return to Orbit
Journal Text: 187:33:14
Journal Text: 187:38:44
Journal Text: 187:44:24
ALL NASA FOOTAGE USED IN THIS FILM IS PUBLIC DOMAIN. THE USE OF ANY COPYRIGHTED MATERIAL IS USED UNDER THE GUIDELINES OF "FAIR USE" IN TITLE 17 § 107 OF THE UNITED STATES CODE. SUCH MATERIAL REMAINS THE COPYRIGHT OF THE ORIGINAL HOLDER AND IS USED HERE FOR THE PURPOSES OF EDUCATION, COMPARISON, AND CRITICISM ONLY. NO INFRINGEMENT OF COPYRIGHT IS INTENDED.
Astronaut Calls Split-Rock a Dog- Just Like Fake Dog Rocks at Disneyland.
While the Astronauts are Working Behind the Disney Dog Shaped Split-Rock, the TV Camera Moves Around Looking at the Other Fake Dog Shaped Rocks Created by Disney Studios.
This video as you hear & see it, is located for download at NASA site:
http://history.nasa.gov/alsj/a17/video17.html
Apollo 17 Video Library
Geology Station 6
Journal Text: 165:18:56
ALL NASA FOOTAGE USED IN THIS FILM IS PUBLIC DOMAIN. THE USE OF ANY COPYRIGHTED MATERIAL IS USED UNDER THE GUIDELINES OF "FAIR USE" IN TITLE 17 § 107 OF THE UNITED STATES CODE. SUCH MATERIAL REMAINS THE COPYRIGHT OF THE ORIGINAL HOLDER AND IS USED HERE FOR THE PURPOSES OF EDUCATION, COMPARISON, AND CRITICISM ONLY. NO INFRINGEMENT OF COPYRIGHT IS INTENDED.
Astronaut Calls Rocks Mammals- Houston Asks Are There Any Disney Cat or Dog Rocks in The Nevada Fake Moon Bay.
This video as you hear & see it, is located for download at NASA site:
http://history.nasa.gov/alsj/a17/video17.html
Apollo 17 Video Library
Geology Station 5 at Camelot Crater
Journal Text: 146:30:19
ALL NASA FOOTAGE USED IN THIS FILM IS PUBLIC DOMAIN. THE USE OF ANY COPYRIGHTED MATERIAL IS USED UNDER THE GUIDELINES OF "FAIR USE" IN TITLE 17 § 107 OF THE UNITED STATES CODE. SUCH MATERIAL REMAINS THE COPYRIGHT OF THE ORIGINAL HOLDER AND IS USED HERE FOR THE PURPOSES OF EDUCATION, COMPARISON, AND CRITICISM ONLY. NO INFRINGEMENT OF COPYRIGHT IS INTENDED.
